Seelenberger Alexander A. — SEC Form 4 filings

SEC reporting owner CIK 1832562. 3 Form 4 filings on record with FilingPulse; latest filed 2024-08-14.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-03-08 to 2024-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Vincerx Pharma, Inc. (VINC)Chief Financial Officer316

Form 4 filings — Seelenberger Alexander A.

FiledFormIssuerReported transactionsSource
2024-08-144Vincerx Pharma, Inc. (VINC)Disposition to issuer (D): 200,000 (derivative) · Grant/award (A): 200,000 (derivative) · Disposition to issuer (D): 55,250 (derivative) · Grant/award (A): 55,250 (derivative) · Disposition to issuer (D): 58,000 (derivative) · Grant/award (A): 58,000 (derivative) · +8 moreEDGAR
2024-05-294Vincerx Pharma, Inc. (VINC)Grant/award (A): 31,250 (derivative) @ $0EDGAR
2024-03-084Vincerx Pharma, Inc. (VINC)Grant/award (A): 93,750 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1832562 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →